Clearside Biomedical (NASDAQ:CLSD)

Ocular microinjection platform for non-surgical, targeted delivery of drugs and proteins into the suprachoroidal space

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Clearside Biomedical (NASDAQ:CLSD) plus 5267 other startups.

Start Free 7 Day Trial Now

Learn More About Clearside Biomedical (NASDAQ:CLSD)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More

Our Clients